ctrl K

Price Alert

Eucrates Biomedical Acqui... (EUCRU)

NASDAQ: EUCRU · Real-Time Price · USD

10.02

-0.07 (-0.69%)

At close: Apr 26, 2023, 9:59 PM

Eucrates Biomedical Acquisition Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-263K	-167K	-137K	-131K	-493K	-260K	-124K	-125K
Interest Income	289.1K	222.44K	136.43K	53.17K	-28.11K	7.21K	7.23K	13.68K
Pretax Income	141.75K	521.34K	431.66K	1.32M	1.2M	950.22K	630.59K	1.99M
Net Income	546.7K	1.21M	905.24K	2.78M	2.89M	950.22K	630.59K	1.99M
Selling & General & Admin	268.51K	n/a	137.48K	131.04K	509.63K	259.86K	124.42K	125.35K
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	-5.32K	166.87K	-1.2K	n/a	n/a	n/a	n/a	n/a
Operating Expenses	263.19K	166.87K	137.48K	131.04K	509.63K	259.86K	124.42K	125.35K
Interest Expense	n/a	n/a	n/a	n/a	-1.69M	7.21K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	263.19K	166.87K	137.48K	131.04K	509.63K	259.86K	124.42K	125.35K
Income Tax Expense	-405K	-688K	-474K	-1.46M	-1.69M	n/a	n/a	n/a
Shares Outstanding (Basic)	2.98M	10.48M	10.48M	2.98M	4.21M	2.98M	4.21M	4.41M
Shares Outstanding (Diluted)	2.98M	13.46M	13.46M	13.46M	13.46M	13.46M	13.46M	13.46M
EPS (Basic)	0.18	0.17	0.14	0.44	0.69	0.32	0.15	0.45
EPS (Diluted)	0.18	0.09	0.07	0.21	0.21	0.07	0.05	0.15
EBITDA	-26.23K	-509K	-571K	-1.47M	1.2M	957.43K	630.59K	1.99M
EBIT	-263K	-167K	-41.92K	-131K	-493K	957.43K	-124K	-125K
Depreciation & Amortization	236.96K	-342K	-434K	-1.34M	1.69M	1.22M	755.02K	2.12M